Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
POINT Biopharma Global Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $218.99M | $45.73M - $428.68M | $187.01M | $0.239 | 8 |
| Dec 2024 | $144.50M | $9.00M - $280.00M | $123.40M | -$1.40 | 7 |
| Dec 2023 | $16.55M | $14.00M - $33.42M | $14.13M | -$1.12 | 9 |
| Dec 2022 | $240.90M | $50.31M - $471.58M | $205.73M | $0.95 | 3 |